/neuro/taxonomy/term/830/all en /neuro/article/patients-open-science/case-patients-donating-samples-research “We need a discovery that will slow or stop the progression of this debilitating disease. We need a cure” Thu, 11 Apr 2024 19:08:51 +0000 Shawn Hayward 6001 at /neuro /neuro/article/dr-ronald-postuma-appointed-director-division-neurology-muhc Message from the Director, Dr. Guy Rouleau. Fri, 02 Feb 2024 22:20:45 +0000 Guy Rouleau 5937 at /neuro /neuro/channels/news/neurological-disease-paradigm-shift-354315 <h2><b>Researchers propose a new model for classifying Parkinson’s</b></h2> <p> </p> <p>One of the things that makes developing effective treatments for Parkinson’s disease so challenging is its complexity. While some forms are caused by genetics, others have environmental factors, and patients can show a wide range of symptoms of varying severity. Diagnosis of Parkinson’s is also currently made very late, after the disease may have been in the brain for a decade or more.</p> Tue, 16 Jan 2024 16:23:16 +0000 shawn.hayward@mcgill.ca 5893 at /neuro /neuro/article/research/shedding-light-parkinsons-toward-new-treatments-and-cures An observational study seeks people recently diagnosed with Parkinson’s, and those with risk factors. Thu, 02 Jun 2022 20:26:58 +0000 Sophie Lorenzo 5466 at /neuro /neuro/channels/news/sleep-disorder-linked-neurodegeneration-focus-35-million-usd-grant-333885 <h2><b>International team seeks hidden signs of brain damage in REM behavior disorder</b></h2> <p>People with rapid eye movement (REM) sleep behavior disorder act out their dreams. While sleeping safely in bed, for example, they might throw up their arms to catch an imaginary ball, or try to run from an illusory assailant. Such actions are more than just a nuisance. People with the disorder have a 50 to 80 per cent chance of developing a serious neurodegenerative disease within a decade of diagnosis.</p> Mon, 04 Oct 2021 16:48:10 +0000 shawn.hayward@mcgill.ca 5143 at /neuro /neuro/channels/news/april-parkinsons-awareness-month-267372 <h2><strong>Multidisciplinary care and cutting-edge research share space at The Neuro</strong></h2> <p>The Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties. Characteristic symptoms include tremor, rigidity and gait dysfunction, mood and sleep disorders, and cognitive degeneration. About 100,000 Canadians have PD.</p> Wed, 29 Mar 2017 19:05:27 +0000 jennifer.lockerby@mail.mcgill.ca 2551 at /neuro /neuro/channels/news/using-sleep-disorder-predict-parkinsons-disease-295138 <p><strong>Large international study will help select and categorize patients for better clinical trials</strong></p> <p>A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development.</p> Mon, 04 Mar 2019 14:46:28 +0000 shawn.hayward@mcgill.ca 3402 at /neuro /neuro/channels/news/neuro-marks-parkinsons-awareness-month-286466 <p>April is Parkinson’s Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson’s disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.</p> Mon, 09 Apr 2018 17:59:06 +0000 shawn.hayward@mcgill.ca 3013 at /neuro /neuro/channels/news/april-parkinsons-disease-awareness-month-244818 <p>The Montreal Neurological Institute and Hospital - The Neuro, ƻ����Ժ and the ƻ����Ժ Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.</p> <p><strong>The Neuro to introduce experimental drug treatment </strong></p> Thu, 02 Apr 2015 13:43:31 +0000 anita.kar@mcgill.ca 1397 at /neuro /neuro/channels/news/parkinsons-disease-new-tool-health-care-professionals-aims-improve-diagnosis-and-advance-treatment-256826 <p><em>The results of their study, published in the journal Movement Disorders.</em></p> <p><br /> A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society (MDS), have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson’s disease, especially in the early stages. The results of their study, published in the journal <em>Movement Disorders</em>, could also have a major impact on the quality of research on Parkinson’s disease. </p> Tue, 17 Nov 2015 22:08:28 +0000 sandra.mcpherson@ƻ����Ժ.Ca 1820 at /neuro /neuro/channels/news/parkinsons-month-2016 <h2>The Neuro – A Major Force in Parkinson’s Disease Research and Treatment</h2> Mon, 04 Apr 2016 20:00:13 +0000 shawn.hayward@mcgill.ca 1973 at /neuro /neuro/ronald-b-postuma-md Thu, 27 May 2021 05:07:41 +0000 iain.cook@mcgill.ca 3678 at /neuro